Perrine Garde‐Granger

485 total citations
12 papers, 349 citations indexed

About

Perrine Garde‐Granger is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Perrine Garde‐Granger has authored 12 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Perrine Garde‐Granger's work include Ovarian cancer diagnosis and treatment (4 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Perrine Garde‐Granger is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Endometrial and Cervical Cancer Treatments (2 papers). Perrine Garde‐Granger collaborates with scholars based in Canada. Perrine Garde‐Granger's co-authors include Alain Piché, Isabelle Matte, Denis Lane, Claudine Rancourt, Claude Laplante, Paul Bessette, Alex Carignan, Sameh Geha, François‐Michel Boisvert and Simon Ouellet and has published in prestigious journals such as Scientific Reports, International Journal of Cancer and Molecular Cancer.

In The Last Decade

Perrine Garde‐Granger

12 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Perrine Garde‐Granger Canada 11 166 125 117 117 52 12 349
Mari Bunkholt Elstrand Norway 10 161 1.0× 157 1.3× 140 1.2× 94 0.8× 79 1.5× 11 392
Alison Freimund Australia 8 276 1.7× 139 1.1× 57 0.5× 126 1.1× 50 1.0× 11 375
C Annicchiarico Italy 12 115 0.7× 136 1.1× 105 0.9× 119 1.0× 48 0.9× 20 357
Ahmed Kamel Egypt 5 111 0.7× 90 0.7× 46 0.4× 123 1.1× 40 0.8× 15 287
Hualei Bu China 11 118 0.7× 173 1.4× 36 0.3× 102 0.9× 91 1.8× 24 354
Brian C. Willis United States 7 162 1.0× 79 0.6× 54 0.5× 52 0.4× 52 1.0× 9 305
K Ashihara Japan 11 139 0.8× 200 1.6× 53 0.5× 88 0.8× 141 2.7× 16 407
Luisa Sánchez‐Lorenzo Spain 7 190 1.1× 92 0.7× 44 0.4× 67 0.6× 30 0.6× 23 288
Sue Ghosh United States 5 144 0.9× 269 2.2× 74 0.6× 82 0.7× 143 2.8× 5 474

Countries citing papers authored by Perrine Garde‐Granger

Since Specialization
Citations

This map shows the geographic impact of Perrine Garde‐Granger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perrine Garde‐Granger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perrine Garde‐Granger more than expected).

Fields of papers citing papers by Perrine Garde‐Granger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perrine Garde‐Granger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perrine Garde‐Granger. The network helps show where Perrine Garde‐Granger may publish in the future.

Co-authorship network of co-authors of Perrine Garde‐Granger

This figure shows the co-authorship network connecting the top 25 collaborators of Perrine Garde‐Granger. A scholar is included among the top collaborators of Perrine Garde‐Granger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perrine Garde‐Granger. Perrine Garde‐Granger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Matte, Isabelle, Perrine Garde‐Granger, Paul Bessette, & Alain Piché. (2019). Serum CA125 and ascites leptin level ratio predicts baseline clinical resistance to first-line platinum-based treatment and poor prognosis in patients with high grade serous ovarian cancer.. PubMed. 9(1). 160–170. 18 indexed citations
2.
Matte, Isabelle, Perrine Garde‐Granger, Paul Bessette, & Alain Piché. (2019). Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway. BMC Cancer. 19(1). 406–406. 30 indexed citations
3.
Lane, Denis, Isabelle Matte, Perrine Garde‐Granger, Paul Bessette, & Alain Piché. (2018). Ascites IL-10 Promotes Ovarian Cancer Cell Migration. Cancer Microenvironment. 11(2-3). 115–124. 26 indexed citations
4.
5.
6.
Matte, Isabelle, Perrine Garde‐Granger, Claude Laplante, et al.. (2016). Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions. Clinical & Experimental Metastasis. 33(8). 839–852. 34 indexed citations
7.
Lane, Denis, Isabelle Matte, Claude Laplante, et al.. (2016). CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling. Molecular Cancer. 15(1). 58–58. 57 indexed citations
8.
Allaire, Joannie M., Étienne Lemieux, Jean‐Philippe Babeu, et al.. (2016). Loss of mesenchymal bone morphogenetic protein signaling leads to development of reactive stroma and initiation of the gastric neoplastic cascade. Scientific Reports. 6(1). 32759–32759. 13 indexed citations
9.
Garant, Aurélie, et al.. (2016). Whole Abdominal-Pelvic Radiotherapy in the Management of Primary Ewing Sarcoma of the Peritoneal Cavity. Cureus. 8(1). e455–e455. 1 indexed citations
10.
Lane, Denis, Isabelle Matte, Perrine Garde‐Granger, et al.. (2015). Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers. BMC Cancer. 15(1). 492–492. 62 indexed citations
11.
Matte, Isabelle, Denis Lane, Claude Laplante, et al.. (2014). Ovarian cancer ascites enhance the migration of patient‐derived peritoneal mesothelial cells viacMet pathway through HGF‐dependent and ‐independent mechanisms. International Journal of Cancer. 137(2). 289–298. 29 indexed citations
12.
Lane, Denis, Isabelle Matte, Claude Laplante, et al.. (2013). Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis. Journal of Ovarian Research. 6(1). 82–82. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mari Bunkholt Elstrand Breakdown of academic impact, for papers by Alison Freimund Breakdown of academic impact, for papers by C Annicchiarico Breakdown of academic impact, for papers by Ahmed Kamel Breakdown of academic impact, for papers by Hualei Bu Breakdown of academic impact, for papers by Brian C. Willis Breakdown of academic impact, for papers by K Ashihara Breakdown of academic impact, for papers by Luisa Sánchez‐Lorenzo Breakdown of academic impact, for papers by Sue Ghosh
Rankless by CCL
2026